Biotech
Caris Life Sciences
Caris Life Sciences raises $168M Growth at $1.9B valuation
$168M
Total Raised
Growth
Latest Round
2018
Founded
1000+
Employees
Irving, TX
1 min read
Quick Facts
Valuation
$1.9B
Latest Round Size
$168M
Latest Round Date
October 2025
Caris Life Sciences: Growth Funding Round
Caris Life Sciences has successfully raised $168M in Growth funding, reaching a valuation of $1.9B.
Company Overview
Molecular profiling and AI/ML for precision medicine development
Funding Details
The Growth round was led by Braidwell.
Company Information
- Headquarters: Irving, TX
- Founded: 2018
- Employees: 1000+
- Category: Biotech
Investment
Caris Life Sciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Braidwell: Verified investor in Growth
Key Investors
Braidwell
Lead Investor
Verified investor in Growth
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M